The Impact of Graft-versus-Host Disease on the Relapse Rate in Patients with Lymphoma Depends on the Histological Subtype and the Intensity of the Conditioning Regimen

被引：47

作者：

Urbano-Ispizua, Alvaro ^{[1
,2
]}

Pavletic, Steven Z. ^{[3
]}

Flowers, Mary E. ^{[4
]}

Klein, John P. ^{[5
,6
]}

Zhang, Mei-Jie ^{[5
,6
]}

Carreras, Jeanette ^{[5
]}

Montoto, Silvia ^{[7
]}

Perales, Miguel-Angel ^{[8
]}

Aljurf, Mahmoud D. ^{[9
]}

Akpek, Goerguen ^{[10
]}

Bredeson, Christopher N. ^{[11
,12
]}

Costa, Luciano J. ^{[13
]}

Dandoy, Christopher ^{[14
]}

Freytes, Cesar O. ^{[15
,16
]}

Fung, Henry C. ^{[17
]}

Gale, Robert Peter ^{[18
]}

Gibson, John ^{[19
]}

Hamadani, Mehdi ^{[5
]}

Hayashi, Robert J. ^{[20
]}

Inamoto, Yoshihiro ^{[4
]}

Inwards, David J. ^{[21
]}

Lazarus, Hillard M. ^{[22
]}

Maloney, David G. ^{[4
]}

Martino, Rodrigo ^{[23
]}

Munker, Reinhold ^{[24
]}

Nishihori, Taiga ^{[25
]}

Olsson, Richard F. ^{[26
,27
]}

Rizzieri, David A. ^{[28
]}

Reshef, Ran ^{[29
]}

Saad, Ayman ^{[13
]}

Savani, Bipin N. ^{[30
]}

Schouten, Harry C. ^{[31
]}

Smith, Sonali M. ^{[32
]}

Socie, Gerard ^{[33
]}

Wirk, Baldeep ^{[34
]}

Yu, Lolie C. ^{[35
]}

Saber, Wael ^{[5
]}

机构：

[1] Univ Barcelona, Hosp Clin, IDIBAPS, Dept Hematol, Barcelona, Spain

[2] Inst Res Josep Carreras, Barcelona, Spain

[3] NCI, Expt Transplantat & Immunol Branch, Ctr Canc Res, Bethesda, MD 20892 USA

[4] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA

[5] Med Coll Wisconsin, Dept Med, Ctr Int Blood & Marrow Transplant Res, Milwaukee, WI 53226 USA

[6] Med Coll Wisconsin, Inst Hlth & Soc, Div Biostat, Milwaukee, WI 53226 USA

[7] Barts Hlth NHS Trust, St Bartholomews Hosp, Dept Haematooncol, London, England

[8] Mem Sloan Kettering Canc Ctr, Dept Med, Bone Marrow Transplant Serv, New York, NY 10021 USA

[9] King Faisal Specialist Hosp Ctr & Res, Dept Oncol, Riyadh, Saudi Arabia

[10] Banner MD Anderson Canc Ctr, Hematol Oncol Sect, Gilbert, AZ USA

[11] Ottawa Hosp, Blood & Marrow Transplant Program, Ottawa, ON, Canada

[12] Ottawa Hosp, Res Inst, Ottawa, ON, Canada

[13] Univ Alabama Birmingham, Dept Med, Div Hematol Oncol, Birmingham, AL 35294 USA

[14] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA

[15] South Texas Vet Hlth Care Syst, San Antonio, TX USA

[16] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA

[17] Temple Hlth, Fox Chase Canc Ctr, Dept Med Oncol, Philadelphia, PA USA

[18] Univ London Imperial Coll Sci Technol & Med, Dept Med, Div Expt Med, Hematol Res Ctr, London, England

[19] Royal Prince Alfred Hosp, Inst Haematol, Camperdown, NSW 2050, Australia

[20] Washington Univ, Sch Med, Dept Pediat, Div Pediat Hematol Oncol, St Louis, MO 63110 USA

[21] Mayo Clin, Div Hematol, Rochester, MN USA

[22] Univ Hosp Case Med Ctr, Seidman Canc Ctr, Cleveland, OH USA

[23] Hosp Santa Creu & Sant Pau, Div Hematol, Barcelona, Spain

[24] Louisiana State Univ Hlth, Dept Internal Med, Div Hematol Oncol, Shreveport, LA USA

[25] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Med Oncol, Tampa, FL 33612 USA

[26] Karolinska Inst, Dept Lab Med, Div Therapeut Immunol, Stockholm, Sweden

[27] Uppsala Univ, Ctr Clin Res Sormland, Uppsala, Sweden

[28] Duke Univ, Div Hematol Malignancies & Cellular Therapy, Durham, NC USA

[29] Univ Penn, Dept Med, Abramson Canc Ctr, Med Ctr, Philadelphia, PA 19104 USA

[30] Vanderbilt Univ, Med Ctr, Dept Med, Div Hematol Oncol, Nashville, TN USA

[31] Acad Ziekenhuis, Dept Hematol, Maastricht, Netherlands

[32] Univ Chicago, Hematol Oncol Sect, Chicago, IL 60637 USA

[33] Hop St Louis, Dept Hematol, Paris, France

[34] SUNY Stony Brook, Med Ctr, Dept Internal Med, Stony Brook, NY 11794 USA

[35] Louisiana State Univ, Med Ctr, Childrens Hosp, Div Hematol Oncol,Ctr Canc & Blood Disorders, New Orleans, LA USA

来源：

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2015年 / 21卷 / 10期

关键词：

Graft-versus-host disease; Lymphoma; STEM-CELL TRANSPLANTATION; BONE-MARROW TRANSPLANT; ALLOGENEIC TRANSPLANTATION; HODGKINS-LYMPHOMA; EUROPEAN GROUP; BLOOD; INFUSIONS; REMISSIONS; REGISTRY;

D O I：

10.1016/j.bbmt.2015.05.010

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The purpose of this study was to analyze the impact of graft-versus-host disease (GVHD) on the relapse rate of different lymphoma subtypes after allogeneic hematopoietic cell transplantation (allo-HCT). Adult patients with a diagnosis of Hodgkin lymphoma, diffuse large B cell lymphoma, follicular lymphoma (FL), peripheral T cell lymphoma, or mantle cell lymphoma (MCL) undergoing HLA-identical sibling or unrelated donor hematopoietic cell transplantation between 1997 and 2009 were included. Two thousand six hundred eleven cases were included. A reduced-intensity conditioning (RIC) regimen was used in 62.8% of the transplantations. In a multivariate analysis of myeloablative cases (n = 970), neither acute (aGVHD) nor chronic GVHD (cGVHD) were significantly associated with a lower incidence of relapse/progression in any lymphoma subtype. In contrast, the analysis of RIC cases (n = 1641) showed that cGVHD was associated with a lower incidence of relapse/progression in FL (risk ratio [RR],.51; P = 3.049) and in MCL (RR,.41; P = .019). Patients with FL or MCL developing both aGVHD and cGVHD had the lowest risk of relapse (RR,.14; P = .007; and RR,.15; P = .0019, respectively). Of interest, the effect of GVHD on decreasing relapse was similar in patients with sensitive disease and chemoresistant disease. Unfortunately, both aGVHD and cGVHD had a deleterious effect on treatment-related mortality and overall survival (OS) in FL cases but did not affect treatment-related mortality, OS or PFS in MCL. This study reinforces the use of RIC allo-HCT as a platform for immunotherapy in FL and MCL patients. (C) 2015 American Society for Blood and Marrow Transplantation.

引用

页码：1746 / 1753

页数：8

共 27 条

[21] CHRONIC GRAFT VERSUS HOST SYNDROME IN MAN - A LONG-TERM CLINICOPATHOLOGIC STUDY OF 20 SEATTLE PATIENTS [J].

SHULMAN, HM ;

SULLIVAN, KM ;

WEIDEN, PL ;

MCDONALD, GB ;

STRIKER, GE ;

SALE, GE ;

HACKMAN, R ;

TSOI, M ;

STORB, R ;

THOMAS, ED .

AMERICAN JOURNAL OF MEDICINE, 1980, 69 (02) :204-217

[22] Graft-Versus-Host Disease and Graft-Versus-Tumor Effects After Allogeneic Hematopoietic Cell Transplantation [J].

Storb, Rainer ;

Gyurkocza, Boglarka ;

Storer, Barry E. ;

Sorror, Mohamed L. ;

Blume, Karl ;

Niederwieser, Dietger ;

Chauncey, Thomas R. ;

Pulsipher, Michael A. ;

Petersen, Finn B. ;

Sahebi, Firoozeh ;

Agura, Edward D. ;

Hari, Parameswaran ;

Bruno, Benedetto ;

McSweeney, Peter A. ;

Maris, Michael B. ;

Maziarz, Richard T. ;

Langston, Amelia A. ;

Bethge, Wolfgang ;

Vindelov, Lars ;

Franke, Georg-Nikolaus ;

Laport, Ginna G. ;

Yeager, Andrew M. ;

Huebel, Kai ;

Deeg, H. Joachim ;

Georges, George E. ;

Flowers, Mary E. D. ;

Martin, Paul J. ;

Mielcarek, Marco ;

Woolfrey, Ann E. ;

Maloney, David G. ;

Sandmaier, Brenda M. .

JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (12) :1530-1538

[23] Mature results of the M. D. Anderson Cancer Center risk-adapted transplantation strategy in mantle cell lymphoma [J].

Tam, Constantine S. ;

Bassett, Roland ;

Ledesma, Celina ;

Korbling, Martin ;

Alousi, Amin ;

Hosing, Chitra ;

Kebraei, Partow ;

Harrell, Robyn ;

Rondon, Gabriela ;

Giralt, Sergio A. ;

Anderlini, Paolo ;

Popat, Uday ;

Pro, Barbara ;

Samuels, Barry ;

Hagemeister, Frederick ;

Medeiros, L. Jeffrey ;

Champlin, Richard E. ;

Khouri, Issa F. .

BLOOD, 2009, 113 (18) :4144-4152

[24] T-Cell-Depleted Reduced-Intensity Transplantation Followed by Donor Leukocyte Infusions to Promote Graft-Versus-Lymphoma Activity Results in Excellent Long-Term Survival in Patients With Multiply Relapsed Follicular Lymphoma [J].

Thomson, Kirsty J. ;

Morris, Emma C. ;

Milligan, Don ;

Parker, Anne N. ;

Hunter, Ann E. ;

Cook, Gordon ;

Bloor, Adrian J. C. ;

Clark, Fiona ;

Kazmi, Majid ;

Linch, David C. ;

Chakraverty, Ronjon ;

Peggs, Karl S. ;

Mackinnon, Stephen .

JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (23) :3695-3700

[25] Comparison of autologous and allogeneic hematopoietic stem cell transplantation for follicular lymphoma [J].

van Besien, K ;

Loberiza, FR ;

Bajorunaite, R ;

Armitage, JO ;

Bashey, A ;

Burns, LJ ;

Freytes, CO ;

Gibson, J ;

Horowitz, MM ;

Inwards, DJ ;

Marks, DI ;

Martino, R ;

Maziarz, RT ;

Molina, A ;

Pavlovsky, S ;

Pecora, AL ;

Schouten, HC ;

Shea, TC ;

Lazarus, HM ;

Rizzo, JD ;

Vose, JM .

BLOOD, 2003, 102 (10) :3521-3529

[26]

van Besien Koen, 2009, Hematology Am Soc Hematol Educ Program, P610, DOI 10.1182/asheducation-2009.1.610

[27] Allogeneic Stem-Cell Transplantation As Salvage Therapy for Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma Relapsing After an Autologous Stem-Cell Transplantation: An Analysis of the European Group for Blood and Marrow Transplantation Registry [J].

van Kampen, Roel J. W. ;

Canals, Carmen ;

Schouten, Harry C. ;

Nagler, Arnon ;

Thomson, Kirsty J. ;

Vernant, Jean-Paul ;

Buzyn, Agnes ;

Boogaerts, Marc A. ;

Luan, Jian-Jian ;

Maury, Sebastien ;

Milpied, Noel J. ;

Jouet, Jean-Pierre ;

Ossenkoppele, Gert J. ;

Sureda, Anna .

JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (10) :1342-1348

← 1 2 3 →